AMED
Amedisys
AMED
AMED
Delisted
AMED was delisted on the 14th of August, 2025.
317 hedge funds and large institutions have $3.2B invested in Amedisys in 2025 Q2 according to their latest regulatory filings, with 64 funds opening new positions, 130 increasing their positions, 87 reducing their positions, and 46 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
2.47% more ownership
Funds ownership: 96.63% → 99.1% (+2.5%)
45% less funds holding in top 10
Funds holding in top 10: 11 → 6 (-5)
97% less call options, than puts
Call options by funds: $8.89M | Put options by funds: $334M
Holders
317
Holding in Top 10
6
Calls
$8.89M
Puts
$334M
Top Buyers
| 1 | +$64.6M | |
| 2 | +$41M | |
| 3 | +$35M | |
| 4 |
Renaissance Technologies
New York
|
+$31.1M |
| 5 |
Neuberger Berman Group
New York
|
+$25.6M |
Top Sellers
| 1 | -$62.7M | |
| 2 | -$41.8M | |
| 3 | -$38.2M | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
-$32.8M |
| 5 |
UOC
UBS O'Connor
Chicago,
Illinois
|
-$32.5M |